Helping pharmacies start offering the HIV prevention pill
Part of Infections clinical trials.
This study helps pharmacies that do not yet offer PrEP (the daily medicine that prevents HIV) learn how to start. It provides training and support on the basics of PrEP and how to make it financially sustainable.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must work at a pharmacy in the United States (as a pharmacist or other staff member).
- Your pharmacy must not currently offer PrEP (the medicine that prevents HIV).
- You must be able to take part in the study activities fully (for health or other reasons).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial trains community pharmacists in Louisiana to prescribe PrEP, a daily medication that prevents HIV, and monitors how well the program works.
This trial tests whether telehealth support can help people who inject drugs start and stay on PrEP (HIV prevention medicine). You will join several sessions and follow-up visits to see if this approach works better than standard care.
This study looks at how well pharmacists can provide PEP and PrEP (HIV prevention pills) using a special software called PEPPI. It aims to make it easier and faster for people to get these medicines.
This study tests whether pharmacies can offer HIV prevention medications (PrEP/PEP) with remote nurse support. It aims to make HIV prevention easier to access in the community.
This study helps young people who are at risk for HIV get on PrEP—a daily pill or shot that prevents HIV. It tests different ways to help you start and stay on PrEP, with care available at clinics or in your community.
This study looks at prescribing PrEP (medication to prevent HIV) in regular doctor's offices. It may help you get easier access to prevention if you're at higher risk.
Hear when a new HIV Prevention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.